Abstract:Chronic obstructive pulmonary disease (COPD) is a chronic respiratory condition characterized by persistent inflammation and oxidative stress, which ultimately leads to progressive restriction of airflow. Extensive research findings have cogently suggested that the dysregulation of essential transition metal ions, notably iron, copper, and zinc, stands as a critical nexus in the perpetuation of inflammatory processes and oxidative damage within the lungs of COPD patients. Unraveling the intricate interplay between metal homeostasis, oxidative stress, and inflammatory signaling is of paramount importance in unraveling the intricacies of COPD pathogenesis. This comprehensive review aims to examine the current literature on the sources, regulation, and mechanisms by which metal dyshomeostasis contributes to COPD progression. We specifically focus on iron, copper, and zinc, given their well-characterized roles in orchestrating cytokine production, immune cell function, antioxidant depletion, and matrix remodeling. Despite the limited number of clinical trials investigating metal modulation in COPD, the advent of emerging methodologies tailored to monitor metal fluxes and gauge responses to chelation and supplementation hold great promise in unlocking the potential of metal-based interventions. We conclude that targeted restoration of metal homeostasis represents a promising frontier for ameliorating pathological processes driving COPD progression.

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to explore the role of metal ion imbalance (especially iron, copper and zinc) in the progression of chronic obstructive pulmonary disease (COPD). Specifically, the paper aims to reveal how the dysregulation of these metal ions drives the pathological process of COPD by triggering oxidative stress and inflammatory responses, and proposes that restoring metal ion homeostasis may be a potential treatment strategy. ### Core of the problem 1. **Relationship between metal ion imbalance and COPD**: - Studies have shown that the dysregulation of transition metal ions such as iron, copper and zinc plays a key role in lung inflammation and oxidative damage in COPD patients. - These metal ions catalyze the generation of reactive oxygen species (ROS) through the Fenton reaction, thereby exacerbating oxidative stress and inflammatory responses. 2. **Mechanism research**: - The paper explores in detail how these metal ions affect cytokine production, immune cell function, antioxidant depletion and matrix remodeling. - It pays special attention to the roles of iron, copper and zinc in the inflammation and oxidative stress pathways to provide strategies for preventing or alleviating disease progression. 3. **Clinical application prospects**: - Although current clinical trials on metal modulation in COPD are limited, emerging methods and techniques (such as monitoring metal mobility and evaluating the effects of chelation and supplementation therapies) offer great potential for metal - based interventions. - Targeted restoration of metal ion homeostasis is considered a promising but under - developed treatment direction for improving the pathological process of COPD. ### Formula example - Fenton reaction formula: \[ \text{Fe}^{2+} + H_2O_2 \rightarrow \text{Fe}^{3+} + OH^{-} + OH^{\cdot} \] This reaction shows how iron ions catalyze hydrogen peroxide to generate hydroxyl radicals, which in turn lead to oxidative stress. Through the above research, the paper hopes to provide a new perspective for understanding the pathogenesis of COPD and a theoretical basis for developing new treatment methods.

Imbalanced and Unchecked: The Role of Metal Dyshomeostasis in Driving COPD Progression

The Role of Trace Elements in COPD: Pathogenetic Mechanisms and Therapeutic Potential of Zinc, Iron, Magnesium, Selenium, Manganese, Copper, and Calcium

Copper homeostasis dysregulation in respiratory diseases: a review of current knowledge

Construction of metal interpretable scoring system and identification of tungsten as a novel risk factor in COPD

The Role of Iron Homeostasis in Remodeling Immune Function and Regulating Inflammatory Disease

The molecular mechanism of ferroptosis and its role in COPD

Iron Dysregulation in Cardiovascular Diseases

Targeting iron-metabolism:a potential therapeutic strategy for pulmonary fibrosis

A hypothesis: Potential contributions of metals to the pathogenesis of pulmonary artery hypertension

Relevance of copper/zinc ratio and its association with redox status in chronic obstructive pulmonary disease

Copper homeostasis and copper-induced cell death in the pathogenesis of cardiovascular disease and therapeutic strategies

Modulation of metal homeostasis for cancer therapy

Blood cadmium concentration and pulmonary function injury: potential mediating role of oxidative stress in chronic obstructive pulmonary disease patients

Iron homeostasis and ferroptosis in human diseases: mechanisms and therapeutic prospects

Inflammatory and Immune Mechanisms in COPD: Current Status and Therapeutic Prospects

Copper homeostasis and cuproptosis in cardiovascular disease therapeutics

Copper homeostasis and cuproptosis in atherosclerosis: metabolism, mechanisms and potential therapeutic strategies

Contribution of cuproptosis and Cu metabolism-associated genes to chronic obstructive pulmonary disease

Exploring Molecular Mechanisms and Biomarkers in COPD: An Overview of Current Advancements and Perspectives

Immune Dysregulation in Chronic Obstructive Pulmonary Disease

Metabolic Derangement of Essential Transition Metals and Potential Antioxidant Therapies